Record #23617

Activation of KRas-ERK1/2 signaling drives the initiation and progression of glioma by suppressing the acetylation of histone H4 at lysine 16

Citation lifecycle

How this paper is being cited

Pre-retraction
2
Same day
0
Post-retraction
2
% post-retraction
50.0%
~1.6 citations/yr before retraction · ~0.3 citations/yr after
citing papers

Who is still citing this work

Loading…